BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia

The fusion oncoprotein BCR-ABL1 exhibits aberrant tyrosine kinase activity and it has been proposed that it deregulates signaling networks involving both transcription factors and non-coding microRNAs that result in chronic myeloid leukemia (CML). Previously, microRNA expression profiling showed der...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Haematologica
Hoofdauteurs: Srutova, Klara, Curik, Nikola, Burda, Pavel, Savvulidi, Filipp, Silvestri, Giovannino, Trotta, Rossana, Klamova, Hana, Pecherkova, Pavla, Sovova, Zofie, Koblihova, Jitka, Stopka, Tomas, Perrotti, Danilo, Polakova, Katerina Machova
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Ferrata Storti Foundation 2018
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6269310/
https://ncbi.nlm.nih.gov/pubmed/30049824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.193086
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items